- Home
- JNVR vs AZTR Comparison
JNVR vs AZTR Comparison
Compare JNVR & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- AZTR
- Stock Information
- Founded
- JNVR 2018
- AZTR 2014
- Country
- JNVR United States
- AZTR United States
- Employees
- JNVR N/A
- AZTR N/A
- Industry
- JNVR Finance: Consumer Services
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- AZTR Health Care
- Exchange
- JNVR Nasdaq
- AZTR Nasdaq
- Market Cap
- JNVR 5.4M
- AZTR 5.2M
- IPO Year
- JNVR 2023
- AZTR 2023
- Fundamental
- Price
- JNVR $5.00
- AZTR $0.29
- Analyst Decision
- JNVR
- AZTR
- Analyst Count
- JNVR 0
- AZTR 0
- Target Price
- JNVR N/A
- AZTR N/A
- AVG Volume (30 Days)
- JNVR 16.2K
- AZTR 271.8K
- Earning Date
- JNVR 03-13-2025
- AZTR 05-08-2025
- Dividend Yield
- JNVR N/A
- AZTR N/A
- EPS Growth
- JNVR N/A
- AZTR N/A
- EPS
- JNVR N/A
- AZTR N/A
- Revenue
- JNVR $2,099,660.00
- AZTR $7,500.00
- Revenue This Year
- JNVR N/A
- AZTR N/A
- Revenue Next Year
- JNVR N/A
- AZTR N/A
- P/E Ratio
- JNVR N/A
- AZTR N/A
- Revenue Growth
- JNVR 4.82
- AZTR N/A
- 52 Week Low
- JNVR $3.37
- AZTR $0.23
- 52 Week High
- JNVR $10.64
- AZTR $12.00
- Technical
- Relative Strength Index (RSI)
- JNVR 54.76
- AZTR 35.02
- Support Level
- JNVR $4.45
- AZTR $0.28
- Resistance Level
- JNVR $5.07
- AZTR $0.35
- Average True Range (ATR)
- JNVR 0.76
- AZTR 0.03
- MACD
- JNVR 0.10
- AZTR -0.01
- Stochastic Oscillator
- JNVR 41.83
- AZTR 18.27
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.